期刊文献+

工业废蛋白用于灵菌红素的发酵工艺优化 被引量:2

An Optimization of Prodigiosin Fermentation Process by Using Proteins from Industrial Waste
下载PDF
导出
摘要 为了加快灵菌红素工业化进程,采用单因素和正交实验,考察了利用工业废蛋白代替蛋白胨作为氮源的可能性.研究结果表明:在工业废蛋白代替蛋白胨的前提下,脯氨酸、乙酸钠、硫酸锰和二甲基亚砜4个因素中,硫酸锰对灵菌红素产量影响最大.采用含有工业废蛋白的优化培养基进行灵菌红素的发酵,灵菌红素产量可达5.91 g/L,相较优化前提高了31%,而每升培养基的成本相较优化前降低了44%.该研究表明,工业废蛋白可替代蛋白胨进行灵菌红素生产,大大降低了灵菌红素的生产成本,加快了其应用开发进程. In order to accelerate the industrialization process of prodigiosin,single-factor and orthogonal experiments are used to explore the possibility of using the proteins from industrial waste to replace peptone as the nitrogen source.The results show that the replacement is feasible and manganese sulfate has the greatest effect on the yield of prodigiosin among the four factors of proline,sodium acetate,manganese sulfate,and dimethyl sulfoxide.By using the optimized medium that contains the proteins from industrial waste for prodigiosin,the yield of prodigiosin can reach 5.91 g/L,increasing 31%,while the cost of medium per liter reduces 44%.This study show that the proteins from industrial waste can replace peptone to produce prodigiosin,which will greatly reduce the production cost and accelerate the development of the application of prodigiosin.
作者 张茜莹 薛常鲁 杨进 庄载铭 刘晓侠 Zhang Qianying;Xue Changlu;Yang Jin;Zhuang Zaiming;Liu Xiaoxia(College of Biological,Chemical Sciences and Engineering,Jiaxing University,Jiaxing,Zhejiang 314001)
出处 《嘉兴学院学报》 2020年第6期136-140,共5页 Journal of Jiaxing University
基金 国家级大学生创新项目(851918522) 嘉兴学院重点SRT项目(85178210)。
关键词 灵菌红素 工业废蛋白 培养基优化 生产成本 prodigiosin proteins from industrial waste medium optimization production cost
  • 相关文献

参考文献6

二级参考文献54

  • 1郝林华,陈靠山,牛德庆,张玉凤.粘质沙雷氏菌(Serratia marcescens)发酵培养基优化的研究[J].海洋科学进展,2006,24(1):66-73. 被引量:21
  • 2郝名慧,楼志华,张梁,石贵阳.一株新粘质沙雷氏菌发酵产红色素及其结构的研究[J].天然产物研究与开发,2007,19(3):439-442. 被引量:28
  • 3刘同军,杨海龙,唐华.灵菌红素的研究进展[J].食品与药品,2007,9(08A):47-51. 被引量:29
  • 4A Hejazi,F R Falkiner. Serratia marcescens[J].Journal of Medical Microbiology,1997,(11):903-912.
  • 5Kwon S K,Park Y K,Kim J F. Genome-wide screening and identification of factors affecting the biosynthesis of prodigiosin by Hahella chejuensis,using Escherichia coli as a surrogate host[J].Applied and Environmental Microbiology,2010,(05):1661-1668.
  • 6Sang B H,Mook H K,Hee Y K. T-cell specific immunosuppression by prodigiosin isolated from Serratia marcescens[J].International Journal of Immunopharmacology,1998,(1-3):1-13.
  • 7Ricardo P T,Beatriz M,Esther L. The prodigiosins,proapoptotic drugs with anticancer properties[J].Biochemical Pharmacology,2003,(08):1447-1452.
  • 8Beatriz M,Wilmar C A,Marc M. DNA interaction and dual topoisomerase Ⅰ and Ⅱ inhibition properties of the anti-tumor drug prodigiosin[J].Toxicological Sciences,2005,(02):870-879.
  • 9Ho T F,Peng Y T,Chuang S M. Prodigiosin down regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines[J].Toxicology and Applied Pharmacology,2009,(02):253-260.
  • 10布坎南 R E;吉本斯 N E.伯杰细菌鉴定手册[M]北京:科学出版社,1984452-454.

共引文献38

同被引文献15

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部